• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid.加工对含 5-氨基水杨酸基质系统释放特性的影响。
AAPS PharmSciTech. 2012 Dec;13(4):1341-7. doi: 10.1208/s12249-012-9861-9. Epub 2012 Sep 29.
2
Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.每日一次、高剂量美沙拉嗪控释肠溶片用于结肠传递:使用 Box-Behnken 设计优化配方变量。
AAPS PharmSciTech. 2011 Dec;12(4):1454-64. doi: 10.1208/s12249-011-9708-9. Epub 2011 Oct 29.
3
The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.聚合物性质对水不溶性控释骨架片直接压片和药物释放的影响。
Int J Pharm. 2014 Jul 20;469(1):94-101. doi: 10.1016/j.ijpharm.2014.04.033. Epub 2014 Apr 16.
4
Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.难溶性药物从含丙烯酸聚合物的热熔挤出物中的控释。
Drug Dev Ind Pharm. 2006 Jun;32(5):569-83. doi: 10.1080/03639040500528996.
5
Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.载有柳氮磺胺吡啶的新型肠溶性微丸片剂,用于控制药物在结肠的释放。
Pharm Dev Technol. 2012 Jan-Feb;17(1):73-83. doi: 10.3109/10837450.2010.516436. Epub 2010 Oct 5.
6
Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.基于注射成型的用丙烯酸载体包衣的美托洛尔控释骨架片的制备和评价。
AAPS PharmSciTech. 2012 Dec;13(4):1197-211. doi: 10.1208/s12249-012-9848-6. Epub 2012 Sep 11.
7
Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.基于Eudragit®E100/Carbopol®971P组合的基质片剂对水溶性模型药物扑热息痛控释及改善压缩性能的评价
AAPS PharmSciTech. 2015 Oct;16(5):1169-79. doi: 10.1208/s12249-015-0301-5. Epub 2015 Feb 28.
8
[Preparation of tetrandrine alginate calcium sustained release gel pellets].汉防己甲素海藻酸钙缓释凝胶微丸的制备
Zhong Yao Cai. 2008 Jan;31(1):131-4.
9
The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.通过多变量数据分析评估热处理和不溶性聚(甲基)丙烯酸酯类型对羟丙甲纤维素基质片剂中高溶性药物溶出行为的影响。
Pharm Dev Technol. 2017 Mar;22(2):206-217. doi: 10.1080/10837450.2016.1193191. Epub 2017 Jan 6.
10
In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.含纤维素聚合物混合物的亲水基质片剂中酮洛芬的体外释放。
Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24.

引用本文的文献

1
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.开发一种在速释固定剂量青蒿琥酯/本芴醇片中溶出度测定法。
Malar J. 2020 Apr 7;19(1):139. doi: 10.1186/s12936-020-03209-5.
2
Power of the Dissolution Test in Distinguishing a Change in Dosage Form Critical Quality Attributes.溶出试验在鉴别剂型关键质量属性变化中的作用。
AAPS PharmSciTech. 2018 Nov;19(8):3328-3332. doi: 10.1208/s12249-018-1197-7. Epub 2018 Oct 22.

本文引用的文献

1
FIP Guidelines for Dissolution Testing of Solid Oral Products.FIP 指导原则:固体制剂溶出度测试
J Pharm Sci. 2018 Dec;107(12):2995-3002. doi: 10.1016/j.xphs.2018.08.007. Epub 2018 Aug 25.
2
Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.基于异麦芽糖醇、糖和微晶纤维素惰性核的包衣丸剂药物释放评价。
AAPS PharmSciTech. 2010 Mar;11(1):383-91. doi: 10.1208/s12249-010-9396-x. Epub 2010 Mar 17.
3
Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.热治疗对聚丙烯酸树脂RS基质影响的机理评估
Farmaco. 2005 Nov-Dec;60(11-12):925-30. doi: 10.1016/j.farmac.2005.07.009. Epub 2005 Oct 11.
4
Gastroretentive delivery systems: a mini review.胃滞留给药系统:一篇综述短文
Drug Dev Ind Pharm. 2004;30(10):1019-28. doi: 10.1081/ddc-200040239.
5
Formulation aspects in the development of osmotically controlled oral drug delivery systems.渗透控释口服给药系统开发中的制剂方面
J Control Release. 2002 Feb 19;79(1-3):7-27. doi: 10.1016/s0168-3659(01)00550-8.
6
Modeling and comparison of dissolution profiles.溶出曲线的建模与比较
Eur J Pharm Sci. 2001 May;13(2):123-33. doi: 10.1016/s0928-0987(01)00095-1.
7
A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets.一种用于药物线性、脉冲式和延迟释放的灵活技术,便于适应体外难以实现的目标。
J Control Release. 2000 Feb 14;64(1-3):263-8. doi: 10.1016/s0168-3659(99)00147-9.
8
Kinetics of 5-aminosalicylic acid after jejunal instillation in man.人空肠滴注5-氨基水杨酸后的动力学
Br J Clin Pharmacol. 1983 Dec;16(6):738-40. doi: 10.1111/j.1365-2125.1983.tb02254.x.
9
Distribution studies of salicylazosulfapyridine and its metabolites.柳氮磺胺吡啶及其代谢产物的分布研究。
Gastroenterology. 1973 Feb;64(2):240-5.
10
Absorption, metabolism, and excretion of salicylazosulfapyridine in man.柳氮磺胺吡啶在人体中的吸收、代谢及排泄
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539-51. doi: 10.1002/cpt1972134539.

加工对含 5-氨基水杨酸基质系统释放特性的影响。

Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid.

机构信息

Department of Pharmaceutical Technology, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.

出版信息

AAPS PharmSciTech. 2012 Dec;13(4):1341-7. doi: 10.1208/s12249-012-9861-9. Epub 2012 Sep 29.

DOI:10.1208/s12249-012-9861-9
PMID:23054987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3513469/
Abstract

The aim of this study was to investigate the influence of different processing methods on the profiles of 5-aminosalicylic acid dissolution from controlled-release matrix systems based on Eudragit® RL and Eudragit® RS water-insoluble polymers. The pure polymers and their mixtures were studied as matrix formers using different processing methods, i.e., direct compression, wet granulation of the active ingredient with the addition of polymer(s) to the external phase, wet granulation with water, and wet granulation with aqueous dispersions. In comparison with the directly compressed tablets, tablets made by wet granulation with water demonstrated a 6-19% increase in final drug dissolution, whereas when polymers were applied in the external phase during compression, a 0-13% decrease was observed in the amount of drug released. Wet granulation with aqueous polymer dispersions delayed the release of the drug; this was especially marked (a 54-56% decrease in drug release) in compositions, which contained a high amount of Eudragit RL 30D. The release profiles were mostly described by the Korsmeyer-Peppas model or the Hopfenberg model.

摘要

本研究旨在探讨不同加工方法对基于 Eudragit® RL 和 Eudragit® RS 水不溶性聚合物的控释基质系统中 5-氨基水杨酸释放特性的影响。采用不同的加工方法(如直接压片、活性成分与聚合物(s)的外相湿法制粒、水湿法制粒和水性分散体湿法制粒)研究了纯聚合物及其混合物作为基质形成剂。与直接压片相比,水湿法制粒制成的片剂最终药物溶出度提高了 6-19%,而在压缩过程中聚合物应用于外相时,药物释放量减少了 0-13%。水性聚合物分散体湿法制粒延迟了药物的释放;在含有高比例 Eudragit RL 30D 的制剂中,这一现象尤为明显(药物释放减少了 54-56%)。释放曲线主要用 Korsmeyer-Peppas 模型或 Hopfenberg 模型来描述。